Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 9Thyroid Cancer, Papillary 2Differentiated Thyroid Cancer 2Adenocarcinoma, Follicular 2Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation 1Hypothyroidism 1Heterotaxy Syndrome 1

Interventions

Thyroxine 3Triiodothyronine 2Thyrotropin-Releasing Hormone 1Thyrotropin Alfa 1Therapeutics 1Remote Consultation 1Radiotherapy, Intensity-Modulated 1Lenalidomide 1Glucose 1Clinical Protocols 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypothyroidism × Thyrotropin Alfa × Clear all
NCT00001730 2008-03-04

Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.

National Institutes of Health Clinical Center (CC)

Phase 4 Completed
20 enrolled
Head & Neck

Hypothyroidism, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡